封面
市场调查报告书
商品编码
1891207

体外毒性测试市场按类型、最终用户和地区划分

In Vitro Toxicity Testing Market, By Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年体外毒性测试市场规模预计为 100.4 亿美元,预计到 2032 年将达到 243.6 亿美元,2025 年至 2032 年的复合年增长率为 13.5%。

报告内容 报告详情
基准年: 2024 2025年市场规模: 100.4亿美元
历史数据时期: 2020-2024 预测期: 2025-2032
预测期间(2025-2032年): 13.50% 2032 年的预测值: 243.6亿美元

目前正在进行研究活动,探索替代传统动物毒性试验的方法,例如体外毒性试验,并辅以电脑模拟(in silico)和化学试管内(in chemico)等方法。代谢、毒代动力学和生物分析研究均以体外毒性试验服务为支撑。为此,建立体外毒性评估工具至关重要,它能够提供必要的测试系统和数据,用于开发系统生物学和生理建模等领域的计算建模工具。由于科学有效性、高效性、成本效益和伦理合理性等诸多因素,利用人类细胞和类器官的体外技术在化学品毒性评估中变得越来越受欢迎。

市场动态

市场主要企业正专注于研发,预计这将推动市场在不久的将来成长。例如,2021年6月21日,经合组织测试指南计画国家协调员工作小组第33次会议(于2021年4月在奥地利举行)核准了修订后的《使用鱼类细胞株进行急性毒性测试方法的测试指南》,该指南由经合组织动物保护国际理事会(ICAPO)发布。大量研究表明,按照经合组织测试指南执行的该测试方法能够有效预测多种化学物质对鱼类的急性毒性。因此,将此测试方法纳入鱼类急性毒性评估的证据权重或综合测试与评估方法(IATA)中,预计将在很大程度上取代鱼类急性毒性测试。

本次调查的主要特点

  • 本报告以 2024 年为基准年,对 2025 年至 2032 年的全球体外毒性测试市场进行了详细分析,并给出了市场规模和复合年增长率。
  • 它还重点介绍了各个细分市场的潜在商机,并为该市场说明了一个有吸引力的投资提案矩阵。
  • 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要企业。
  • 本报告基于以下几个方面,对全球体外毒性测试市场的主要参与企业进行了分析:公司概况、产品系列、关键亮点、财务表现和策略。
  • 本报告的研究结果将使负责人和经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 这份全球体外毒性测试市场报告的目标受众是该行业的各种相关人员,包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
  • 相关人员可以透过全球体外毒性测试市场分析中使用的各种策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场范围

  • 报告概述
    • 市场定义和范围
  • 执行摘要
  • 一致性机会图(COM)

第三章:市场动态、监理及趋势分析

  • 市场动态
    • 司机
    • 抑制因素
    • 市场机会
  • 影响分析
  • 近期产品发布
  • 流行病学
  • 合併、收购和合作
  • 法规环境
  • PEST分析

4. 2020-2032年全球体外毒性测试市场(按类型划分)

  • 概述
  • 吸收
  • 危险物质
  • 行政

5. 2020-2032年全球体外毒性测试市场(依最终用户划分)

  • 概述
  • 化妆品产业
  • 製药业
  • 食品工业
  • 化工

6. 2020-2032年全球体外毒性测试市场(按地区划分)

  • 概述
  • 北美洲
    • 美国
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲国家
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 法国
    • 西班牙
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韩国
    • 亚太其他地区
  • 中东
    • GCC
    • 以色列
    • 其他中东地区
  • 非洲
    • 北非
    • 中非
    • 南非

第七章 竞争情势

  • Bio-Rad Laboratories, Inc.
  • Cyprotex
  • Covance Inc.
  • LifeNet Health LifeSciences
  • Creative Bioarray
  • Charles River Laboratories
  • Intertek Group plc
  • LGC Limited
  • SGS Societe Generale de Surveillance SA
  • Preferred Cell Systems
  • Microbac Laboratories, Inc.
  • Eurofins Discovery
  • Creative Biolabs
  • LAUS GmbH
  • Vimta Labs Ltd.

第八章各节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI3855

In Vitro Toxicity Testing Market is estimated to be valued at USD 10.04 Bn in 2025 and is expected to reach USD 24.36 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 10.04 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 13.50% 2032 Value Projection: USD 24.36 Bn

The research activities are conducted to find alternatives to conventional animal-based toxicity testing such as in vitro toxicology assays thatare complemented by in silico and in chemico testing procedures. The metabolic, toxicokinetic, and bioanalytical research is supported by the in vitro toxicity testing services. The establishment of tools for in vitro toxicity assessment, which offers test systems and data required for the development of computer modelling tools for topics like system biology and physiologically based modelling, is a crucial part of this aim. A human cell and organoid-based in vitro technique is becoming increasingly popular for chemical toxicity assessment for a variety of factors including scientific relevance, effectiveness, affordability, and moral propriety.

Market Dynamics

Major players in the market are focused on the research and development activities, and thu,s it is expected to drive the market growth in near future. For instance, on June 21, 2021, a revised test guideline for the fish cell line acute toxicity assay was approved at the 33rd Meeting of the OECD Working Group of the National Coordinators, Austria for the Test Guidelines Programme in April 2021, and it had been published by the International Council on Animal Protection in OECD Programmes (ICAPO). Numerous studies have demonstrated how effectively the assay can forecast acute toxicity to fish for a wide range of chemicals when carried out in compliance with OECD test guidelines. Therefore, by including this assay into a weight of evidence or integrated approach to testing and assessment (IATA) for acute fish toxicity assessment, it has the potential to replace acute fish toxicity testing in a significant way.

Key features of the study

  • This report provides an in-depth analysis of the global in vitro toxicity testing market, and provides market size and compound annual growth rate for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global in vitro toxicity testing market based on the following parameters,company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Bio-Rad Laboratories, Inc., Cyprotex, Covance Inc., LifeNet Health LifeSciences , Creative Bioarray, Charles River Laboratories, Intertek Group plc, LGC Limited, SGS Societe Generale de Surveillance SA, Preferred Cell Systems, Microbac Laboratories, Inc., Eurofins Discovery, Creative Biolabs, LAUS GmbH, and Vimta Labs Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global in vitro toxicity testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global in vitro toxicity testing market

Market Segmentation

  • Global In Vitro Toxicity Testing Market, By Type
    • Absorption
    • Toxic Substances
    • Dose
  • Global In Vitro Toxicity Testing Market, By End User
    • Cosmetics Industry
    • Pharmaceutical Industry
    • Food Industry
    • Chemicals Industry
  • Global In Vitro Toxicity Testing Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Global In Vitro Toxicity Testing Market - Key Players
    • Bio-Rad Laboratories, Inc.
    • Cyprotex
    • Covance Inc.
    • LifeNet Health LifeSciences
    • Creative Bioarray
    • Charles River Laboratories
    • Intertek Group plc
    • LGC Limited
    • SGS Societe Generale de Surveillance SA
    • Preferred Cell Systems
    • Microbac Laboratories, Inc.
    • Eurofins Discovery
    • Creative Biolabs
    • LAUS GmbH
    • Vimta Labs Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global In Vitro Toxicity Testing Market, By Type, 2020-2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Absorption
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Toxic Substances
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Dose
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global In Vitro Toxicity Testing Market, By End User, 2020-2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Cosmetics Industry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pharmaceutical Industry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Food Industry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Chemicals Industry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global In Vitro Toxicity Testing Market, By Region, 2020-2032, (USD Bn)

  • Overview
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User,2020- 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country ,2020- 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • Bio-Rad Laboratories, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cyprotex
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Covance Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • LifeNet Health LifeSciences
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Creative Bioarray
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Charles River Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Intertek Group plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • LGC Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • SGS Societe Generale de Surveillance SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Preferred Cell Systems
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Microbac Laboratories, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eurofins Discovery
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Creative Biolabs
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • LAUS GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Vimta Labs Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

8. Section

  • Research Methodology
  • About Us